Chronic Kidney Disease Trial, Recruiting (NCT04522765)

Chronic Kidney Disease Trial, Recruiting NCT04522765 Sponsor: University of Edinburgh Condition: Chronic Kidney Disease

Printed from Voxsanity (voxsanity.com.au) — NCT04522765 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Chronic Kidney Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who attend NHS Lothian inpatient or outpatient services and are considered to be at increased risk of cardiovascular disease (heart and blood vessel problems)
People who have chronic kidney disease (long-term reduced kidney function), as classified by an established medical guideline called K/DOQI
People who have had a sudden, short-term loss of kidney function (called acute kidney injury), as classified by a guideline called KDIGO
People who have a condition called small vessel vasculitis, which involves inflammation of small blood vessels
People who have received a kidney transplant
People who have donated a kidney
Healthy volunteers from the general community (as a comparison group)

Who may not be able to join:

People under 18 years of age or over 90 years of age
People who are not able to give informed consent (that is, agree to take part after being fully informed about the study)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Neeraj Dhaun, MBChB PhD, University of Edinburgh

Phone: 07968810899

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04522765

Sponsor: University of Edinburgh

Phase: Not Applicable

Status: Recruiting

Condition: Chronic Kidney Disease

Trial contact: 07968810899

More information: https://clinicaltrials.gov/study/NCT04522765

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who attend NHS Lothian inpatient or outpatient services and are considered to be at increased risk of cardiovascular disease (heart and blood vessel problems)
People who have chronic kidney disease (long-term reduced kidney function), as classified by an established medical guideline called K/DOQI
People who have had a sudden, short-term loss of kidney function (called acute kidney injury), as classified by a guideline called KDIGO
People who have a condition called small vessel vasculitis, which involves inflammation of small blood vessels
People who have received a kidney transplant
People who have donated a kidney
Healthy volunteers from the general community (as a comparison group)

Who may not be able to join:

People under 18 years of age or over 90 years of age
People who are not able to give informed consent (that is, agree to take part after being fully informed about the study)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Edinburgh

Registry

ClinicalTrials.gov

Start date

17 March 2020

Est. completion

31 December 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Nocturnal BP dip; Nocturnal arterial stiffness dip

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov